BWX Technologies Cut to Underweight From Equal-Weight by Barclays
Barclays Downgrades BWX Technologies to Underweight, Raises Price Target to $90
Barclays Maintains BWX Technologies(BWXT.US) With Sell Rating, Maintains Target Price $90
Barclays Downgrades BWX Technologies(BWXT.US) to Sell Rating, Raises Target Price to $90
Barclays Downgrades BWX Technologies to Underweight From Equalweight, Price Target to $90
BWX Technologies Unit BWXT Medical and NorthStar Collaborating to Produce Cancer-Fighting Isotope
Express News | Bwxt Medical and Northstar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production
Small and Mid-Cap Stocks Likely to Beat/miss This Earnings Season - BofA
Express News | BWX Technologies Inc - Bwxt and Wyoming Energy Authority Sign Cooperation Agreement to Examine Potential Construction Options in State
Express News | Bwxt to Evaluate Locations for Building New Nuclear Triso Fuel Production Facility to Support Advanced Reactor Deployment
BofA Securities Maintains BWX Technologies(BWXT.US) With Buy Rating
Should You Be Impressed By BWX Technologies, Inc.'s (NYSE:BWXT) ROE?
Deutsche Numis Maintains BWX Technologies(BWXT.US) With Buy Rating, Maintains Target Price $107
Peering Into BWX Technologies's Recent Short Interest
AI consumes too much power, so technology giants are starting to focus on nuclear power.
With the rapid development of AI technology, especially the emergence of large language models and generative AI, the demand for technology in electrical utilities is experiencing explosive growth.
BWX Technologies to Announce Second Quarter 2024 Results on Monday, August 5
BWX Technologies Initiated at Buy by Janney Montgomery Scott
Janney Montgomery Initiates BWX Technologies(BWXT.US) With Buy Rating, Announces Target Price $113
BTIG Research Initiates Coverage on BWX Technologies With Buy Rating, $110 Price Target
BWX Technologies Initiated at Buy by BTIG